Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome

समान संसाधन

• Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment
  द्वारा: Vassilios Lougaris, और अन्य
  प्रकाशित: (2024-05-01)
• Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome
  द्वारा: Surya K. De, और अन्य
  प्रकाशित: (2024-02-01)
• Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)
  द्वारा: María Reyes Abad, और अन्य
  प्रकाशित: (2025-01-01)
• FDA approves leniolisib (Joenja) as the first treatment for APDS: A breaththrough in the field of immunology
  द्वारा: Muhammad Talha, और अन्य
  प्रकाशित: (2024-01-01)
• Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment
  द्वारा: Francesca Conti, और अन्य
  प्रकाशित: (2025-01-01)